Similarities and differences of interstitial lung disease associated with pathogenic variants in SFTPC and ABCA3 in adults

被引:1
|
作者
Diesler, Remi [1 ]
Legendre, Marie [2 ,3 ]
Si-Mohamed, Salim [4 ]
Brillet, Pierre-Yves [5 ]
Wemeau, Lidwine [6 ]
Manali, Effrosyni D. [7 ]
Gagnadoux, Frederic [8 ]
Hirschi, Sandrine [9 ]
Lorillon, Gwenael [10 ]
Reynaud-Gaubert, Martine [11 ]
Bironneau, Vanessa [12 ]
Blanchard, Elodie [13 ]
Bourdin, Arnaud [14 ,15 ]
Dominique, Stephane [16 ]
Justet, Aurelien [17 ]
Macey, Julie [18 ]
Marchand-Adam, Sylvain [19 ]
Morisse-Pradier, Helene [16 ]
Nunes, Hilario [20 ]
Papiris, Spyros A. [7 ]
Traclet, Julie [21 ]
Traore, Ibrahim [22 ]
Crestani, Bruno [23 ]
Amselem, Serge [2 ,3 ]
Nathan, Nadia [3 ,24 ,25 ,26 ]
Borie, Raphael [27 ]
Cottin, Vincent [1 ]
机构
[1] Univ Lyon 1, Hosp Civils Lyon, Dept Resp Med, Dept Resp Med,UMR754,INRAE,ERN LUNG, Lyon, France
[2] Sorbonne Univ, Hop Armand Trousseau, AP HP, UF Genet Mol, Paris, France
[3] Sorbonne Univ, Hop Armand Trousseau, AP HP, Childhood Genet Dis,Inserm,UMR_S933, Paris, France
[4] Claude Bernard Univ Lyon 1, Louis Pradel Hosp, Dept Thorac Imaging, Dept Thorac Imaging,INSA-Lyon,UJM St Etienne,CNRS,, Lyon, France
[5] Hop Avicenne, AP HP, Serv Radiol, Bobigny, France
[6] Hop Calmette, Ctr Reference Constitut Malad Plum Rares, Serv Pneumol & Immuno Allergol, CHU Lille, Lille, France
[7] Gen Univ Hosp Attikon, Natl & Kapodistrian Univ Athens, Med Sch, Pulm Med Dept 2, Athens, Greece
[8] CHU Angers, Serv Pneumol & Allergol, Angers, France
[9] Hop Univ Strasbourg, Serv Pneumol, Strasbourg, France
[10] Hop St Louis, AP HP, Natl Reference Ctr Histiocytoses, Pulm Dept, Paris, France
[11] Aix Marseille Univ, CHU Nord, Ctr Competence Malad Plum Rares,Serv Pneumol Equip, Marseille, France
[12] Univ Poitiers, Serv Pneumol, CHU Poitiers, INSERM,CIC 1402,UFR Med & Pharm,IS ALIVE Res Grp,, Poitiers, France
[13] Hop Haut Leveque, Serv Pneumol, CHU Bordeaux, Bordeaux, France
[14] Univ Montpellier, CHU Montpellier, CNRS, INSERM,Dept Resp Dis, Montpellier, France
[15] Univ Montpellier, CHU Montpellier, CNRS, INSERM,PhyMedExp, Montpellier, France
[16] Dept Pneumol, CHU Rouen, Rouen, France
[17] Univ Caen, Ctr Competence Malad Plum Rares, Serv Pneumol, Serv Pneumol,ISTCT,CNRS,UMR6030,CEA, Caen, France
[18] Univ Hosp Ctr Bordeaux, Resp Med & Cyst Fibrosis Ctr, Bordeaux, France
[19] Univ Tours, Serv Pneumol & Explorat Fonct Respiratoires, Serv Pneumol & Explorat Fonct Respirat, Tours, France
[20] Hop Avicenne, AP HP, Ctr Constitut Malad Plum Rares Adulte, Serv Pneumol & Oncol Thorac, Paris, France
[21] Univ Lyon 1, Hosp Civils Lyon, Dept Resp Med, Hosp civils Lyon, Lyon, France
[22] Serv Pneumol, CHU Jean Minjoz, Besancon, France
[23] Hop Bichat Claude Bernard, AP HP, Serv Pneumol, Paris, France
[24] Sorbonne Univ, Armand Trousseau Hosp, AP HP, Pediat Pulmonol Dept,Inserm,UMR_S933, Paris, France
[25] Sorbonne Univ, Armand Trousseau Hosp, AP HP, Reference Ctr Rare Lung Dis,Inserm,UMR S933, Paris, France
[26] Sorbonne Univ, Armand Trousseau Hosp, AP HP, Lab Childhood Genet Dis,Inserm,UMR S933, Paris, France
[27] Univ Paris Cite, Hop Bichat, AP HP, Federat Hosp Univ Apollo,INSERM,U1152,Serv Pneumol, Paris, France
关键词
ABCA3; adults; fibrosing interstitial lung disease; interstitial lung disease; SFTPC; surfactant; SURFACTANT-PROTEIN-C; IDIOPATHIC PULMONARY-FIBROSIS; GENE-MUTATIONS; TRANSPORTER; HETEROZYGOSITY; CLASSIFICATION; LOCALIZATION; DIAGNOSIS; MUTANTS; BRICHOS;
D O I
10.1111/resp.14667
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background and objective: Variants in surfactant genes SFTPC or ABCA3 are responsible for interstitial lung disease (ILD) in children and adults, with few studies in adults. Methods: We conducted a multicentre retrospective study of all consecutive adult patients diagnosed with ILD associated with variants in SFTPC or ABCA3 in the French rare pulmonary diseases network, OrphaLung. Variants and chest computed tomography (CT) features were centrally reviewed. Results: We included 36 patients (median age: 34 years, 20 males), 22 in the SFTPC group and 14 in the ABCA3 group. Clinical characteristics were similar between groups. Baseline median FVC was 59% ([52-72]) and DLco was 44% ([35-50]). An unclassifiable pattern of fibrosing ILD was the most frequent on chest CT, found in 85% of patients, however with a distinct phenotype with ground-glass opacities and/or cysts. Nonspecific interstitial pneumonia and usual interstitial pneumonia were the most common histological patterns in the ABCA3 group and in the SFTPC group, respectively. Annually, FVC and DLCO declined by 1.87% and 2.43% in the SFTPC group, respectively, and by 0.72% and 0.95% in the ABCA3 group, respectively (FVC, p = 0.014 and DLCO , p = 0.004 for comparison between groups). Median time to death or lung transplantation was 10 years in the SFTPC group and was not reached at the end of follow-up in the ABCA3 group. Conclusion: SFTPC and ABCA3-associated ILD present with a distinct phenotype and prognosis. A radiologic pattern of fibrosing ILD with ground-glass opacities and/or cysts is frequently found in these rare conditions.
引用
收藏
页码:312 / 323
页数:12
相关论文
共 50 条
  • [41] Augmented concentrations of CX3CL1 are associated with interstitial lung disease in systemic sclerosis
    Hoffmann-Vold, Anna-Maria
    Weigt, Stephen Samuel
    Palchevskiy, Vyacheslav
    Volkmann, Elizabeth
    Saggar, Rajan
    Li, Ning
    Midtvedt, Oyvind
    Lund, May Brit
    Garen, Torhild
    Fishbein, Michael C.
    Ardehali, Abbas
    Ross, David J.
    Ueland, Thor
    Aukrust, Pal
    Lynch, Joseph P., III
    Elashoff, Robert M.
    Molberg, Oyvind
    Belperio, John A.
    PLOS ONE, 2018, 13 (11):
  • [42] Surfactant protein D is associated with 3-month mortality of anti-MDA5 antibody-interstitial lung disease
    Lyu, W.
    Zhou, Y.
    Zhuang, Y.
    Liu, Y.
    Cao, M.
    Xin, X.
    Wu, H.
    Wang, J.
    Meng, F.
    Cai, H.
    Dai, J.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2020, 38 (06) : 1068 - 1074
  • [43] SMAD3 pathogenic variants: risk for thoracic aortic disease and associated complications from the Montalcino Aortic Consortium
    Hostetler, Ellen M.
    Regalado, Ellen S.
    Guo, Dong-Chuan
    Hanna, Nadine
    Arnaud, Pauline
    Muino-Mosquera, Laura
    Callewaert, Bert Louis
    Lee, Kwanghyuk
    Leal, Suzanne M.
    Wallace, Stephanie E.
    Rideout, Andrea L.
    Dyack, Sarah
    Aatre, Rajani D.
    Boileau, Catherine
    De Backer, Julie
    Jondeau, Guillaume
    Milewicz, Dianna M.
    JOURNAL OF MEDICAL GENETICS, 2019, 56 (04) : 252 - 260
  • [44] Increased levels of serum galectin-3 in patients with primary Sjogren's syndrome: Associated with interstitial lung disease
    Zhang, Rong
    Sun, Tao
    Song, Liangyue
    Zuo, Dachen
    Xiao, Weiguo
    CYTOKINE, 2014, 69 (02) : 289 - 293
  • [45] Practical considerations in the management of inhaled prostacyclin therapy for pulmonary hypertension associated with interstitial lung disease (WHO group 3)
    Lee, Charlie
    Hamlyn, Joan
    Porcelli, Julie
    Schmit, Ann
    RESPIRATORY MEDICINE, 2022, 196
  • [46] RPA3-UMAD1 rs12702634 and rheumatoid arthritis-associated interstitial lung disease in European ancestry
    Juge, Pierre-Antoine
    Sparks, Jeffrey A.
    Gazal, Steven
    Ebstein, Esther
    Borie, Raphael
    Debray, Marie-Pierre
    Kannengiesser, Caroline
    Mcdermott, Gregory C.
    Cui, Jing
    Hayashi, Keigo
    Doyle, Tracy J.
    van Moorsel, Coline H. M.
    van der Vis, Joanne J.
    Grutters, Jan C.
    Knevel, Rachel
    Heckert, Sascha L.
    Vasarmidi, Eirini
    Antoniou, Katerina M.
    van Mil, Annette H. M. van der Helm
    Boileau, Catherine
    Crestani, Bruno
    Dieude, Philippe
    RHEUMATOLOGY ADVANCES IN PRACTICE, 2024, 8 (02)
  • [47] Serum Rcn3 level is a potential diagnostic biomarker for connective tissue disease-associated interstitial lung disease and reflects the severity of pulmonary function
    Ding, Fangping
    Yang, Liu
    Wang, Yingfei
    Wang, Jing
    Ma, Yingmin
    Jin, Jiawei
    BMC PULMONARY MEDICINE, 2023, 23 (01)
  • [48] Serum Rcn3 level is a potential diagnostic biomarker for connective tissue disease-associated interstitial lung disease and reflects the severity of pulmonary function
    Fangping Ding
    Liu Yang
    Yingfei Wang
    Jing Wang
    Yingmin Ma
    Jiawei Jin
    BMC Pulmonary Medicine, 23
  • [49] Histone Deacetylase 3-Mediated Inhibition of microRNA-19a-3p Facilitates the Development of Rheumatoid Arthritis-Associated Interstitial Lung Disease
    Yuan, Hui
    Jiao, Li
    Yu, Nan
    Duan, Haifeng
    Yu, Yong
    Bai, Yanrong
    FRONTIERS IN PHYSIOLOGY, 2020, 11
  • [50] Pirfenidone inhibits cell fibrosis in connective tissue disease-associated interstitial lung disease by targeting the TNF-α/STAT3/KL6 pathway
    Zuo, Yanhua
    Liu, Jing
    Xu, Huaheng
    Li, Yanxia
    Tao, Ran
    Zhang, Zongfang
    JOURNAL OF THORACIC DISEASE, 2022, 14 (06) : 2089 - 2102